157 related articles for article (PubMed ID: 28439630)
1. Myriocin treatment of CF lung infection and inflammation: complex analyses for enigmatic lipids.
Caretti A; Vasso M; Bonezzi FT; Gallina A; Trinchera M; Rossi A; Adami R; Casas J; Falleni M; Tosi D; Bragonzi A; Ghidoni R; Gelfi C; Signorelli P
Naunyn Schmiedebergs Arch Pharmacol; 2017 Aug; 390(8):775-790. PubMed ID: 28439630
[TBL] [Abstract][Full Text] [Related]
2. Anti-inflammatory action of lipid nanocarrier-delivered myriocin: therapeutic potential in cystic fibrosis.
Caretti A; Bragonzi A; Facchini M; De Fino I; Riva C; Gasco P; Musicanti C; Casas J; Fabriàs G; Ghidoni R; Signorelli P
Biochim Biophys Acta; 2014 Jan; 1840(1):586-94. PubMed ID: 24141140
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of ceramide de novo synthesis by myriocin produces the double effect of reducing pathological inflammation and exerting antifungal activity against A. fumigatus airways infection.
Caretti A; Torelli R; Perdoni F; Falleni M; Tosi D; Zulueta A; Casas J; Sanguinetti M; Ghidoni R; Borghi E; Signorelli P
Biochim Biophys Acta; 2016 Jun; 1860(6):1089-97. PubMed ID: 26922830
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of Sphingolipid Synthesis as a Phenotype-Modifying Therapy in Cystic Fibrosis.
Mingione A; Dei Cas M; Bonezzi F; Caretti A; Piccoli M; Anastasia L; Ghidoni R; Paroni R; Signorelli P
Cell Physiol Biochem; 2020 Jan; 54(1):110-125. PubMed ID: 31999897
[TBL] [Abstract][Full Text] [Related]
5. Interferon regulatory factor 8 regulates expression of acid ceramidase and infection susceptibility in cystic fibrosis.
Gardner AI; Wu Y; Verhaegh R; Liu Y; Wilker B; Soddemann M; Keitsch S; Edwards MJ; Haq IJ; Kamler M; Becker KA; Brodlie M; Gulbins E
J Biol Chem; 2021; 296():100650. PubMed ID: 33839155
[TBL] [Abstract][Full Text] [Related]
6. Acid sphingomyelinase inhibitors normalize pulmonary ceramide and inflammation in cystic fibrosis.
Becker KA; Riethmüller J; Lüth A; Döring G; Kleuser B; Gulbins E
Am J Respir Cell Mol Biol; 2010 Jun; 42(6):716-24. PubMed ID: 19635928
[TBL] [Abstract][Full Text] [Related]
7. Fenretinide corrects newly found ceramide deficiency in cystic fibrosis.
Guilbault C; De Sanctis JB; Wojewodka G; Saeed Z; Lachance C; Skinner TA; Vilela RM; Kubow S; Lands LC; Hajduch M; Matouk E; Radzioch D
Am J Respir Cell Mol Biol; 2008 Jan; 38(1):47-56. PubMed ID: 17656682
[TBL] [Abstract][Full Text] [Related]
8. Ceramide accumulation mediates inflammation, cell death and infection susceptibility in cystic fibrosis.
Teichgräber V; Ulrich M; Endlich N; Riethmüller J; Wilker B; De Oliveira-Munding CC; van Heeckeren AM; Barr ML; von Kürthy G; Schmid KW; Weller M; Tümmler B; Lang F; Grassme H; Döring G; Gulbins E
Nat Med; 2008 Apr; 14(4):382-91. PubMed ID: 18376404
[TBL] [Abstract][Full Text] [Related]
9. Myriocin modulates the altered lipid metabolism and storage in cystic fibrosis.
Signorelli P; Pivari F; Barcella M; Merelli I; Zulueta A; Dei Cas M; Rosso L; Ghidoni R; Caretti A; Paroni R; Mingione A
Cell Signal; 2021 May; 81():109928. PubMed ID: 33482299
[TBL] [Abstract][Full Text] [Related]
10. Prolonged inflammatory response to acute Pseudomonas challenge in interleukin-10 knockout mice.
Chmiel JF; Konstan MW; Saadane A; Krenicky JE; Lester Kirchner H; Berger M
Am J Respir Crit Care Med; 2002 Apr; 165(8):1176-81. PubMed ID: 11956064
[TBL] [Abstract][Full Text] [Related]
11. Pseudomonas aeruginosa microevolution during cystic fibrosis lung infection establishes clones with adapted virulence.
Bragonzi A; Paroni M; Nonis A; Cramer N; Montanari S; Rejman J; Di Serio C; Döring G; Tümmler B
Am J Respir Crit Care Med; 2009 Jul; 180(2):138-45. PubMed ID: 19423715
[TBL] [Abstract][Full Text] [Related]
12. Interleukin-17 Pathophysiology and Therapeutic Intervention in Cystic Fibrosis Lung Infection and Inflammation.
Hsu D; Taylor P; Fletcher D; van Heeckeren R; Eastman J; van Heeckeren A; Davis P; Chmiel JF; Pearlman E; Bonfield TL
Infect Immun; 2016 Sep; 84(9):2410-21. PubMed ID: 27271746
[TBL] [Abstract][Full Text] [Related]
13. Cystic fibrosis fatty acid imbalance is linked to ceramide deficiency and corrected by fenretinide.
Guilbault C; Wojewodka G; Saeed Z; Hajduch M; Matouk E; De Sanctis JB; Radzioch D
Am J Respir Cell Mol Biol; 2009 Jul; 41(1):100-6. PubMed ID: 19059886
[TBL] [Abstract][Full Text] [Related]
14. Neutrophil elastase correlates with increased sphingolipid content in cystic fibrosis sputum.
Karandashova S; Kummarapurugu A; Zheng S; Kang L; Sun S; Rubin BK; Voynow JA
Pediatr Pulmonol; 2018 Jul; 53(7):872-880. PubMed ID: 29624923
[TBL] [Abstract][Full Text] [Related]
15. Ceramide in cystic fibrosis.
Grassmé H; Riethmüller J; Gulbins E
Handb Exp Pharmacol; 2013; (216):265-74. PubMed ID: 23563661
[TBL] [Abstract][Full Text] [Related]
16. Persistent cystic fibrosis isolate Pseudomonas aeruginosa strain RP73 exhibits an under-acylated LPS structure responsible of its low inflammatory activity.
Di Lorenzo F; Silipo A; Bianconi I; Lore' NI; Scamporrino A; Sturiale L; Garozzo D; Lanzetta R; Parrilli M; Bragonzi A; Molinaro A
Mol Immunol; 2015 Feb; 63(2):166-75. PubMed ID: 24856407
[TBL] [Abstract][Full Text] [Related]
17. Glucosylceramide Critically Contributes to the Host Defense of Cystic Fibrosis Lungs.
Kovacic B; Sehl C; Wilker B; Kamler M; Gulbins E; Becker KA
Cell Physiol Biochem; 2017; 41(3):1208-1218. PubMed ID: 28427052
[TBL] [Abstract][Full Text] [Related]
18. Ceramide is increased in the lower airway epithelium of people with advanced cystic fibrosis lung disease.
Brodlie M; McKean MC; Johnson GE; Gray J; Fisher AJ; Corris PA; Lordan JL; Ward C
Am J Respir Crit Care Med; 2010 Aug; 182(3):369-75. PubMed ID: 20395562
[TBL] [Abstract][Full Text] [Related]
19. Ceramide in Pseudomonas aeruginosa infections and cystic fibrosis.
Becker KA; Grassmé H; Zhang Y; Gulbins E
Cell Physiol Biochem; 2010; 26(1):57-66. PubMed ID: 20502005
[TBL] [Abstract][Full Text] [Related]
20. Animal models of chronic lung infection with Pseudomonas aeruginosa: useful tools for cystic fibrosis studies.
Kukavica-Ibrulj I; Levesque RC
Lab Anim; 2008 Oct; 42(4):389-412. PubMed ID: 18782827
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
